Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex, GeneBio Ink Co-marketing Deal

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – AB Sciex and Geneva Bioinformatics (GeneBio) today said that they will co-market products aimed at improving the ability of scientists to conduct rapid screening of large sets of molecules.

The firms will co-market AB Sciex's mass spectrometers and software applications with GeneBio's SmileMS software for advanced library searching capabilities. They said the GeneBio software complements AB Sciex's Analyst and Cliquid software and is fully compatible with AB Sciex's LC/MS/MS libraries for forensic, pesticide, veterinary, and antibiotics analysis.

The combined technologies will "create new opportunities to improve results in clinical and forensic toxicology, among other fields that can take advantage of these capabilities," Joe Anacleto, VP and GM of the applied markets and clinical research business for AB Sciex, said in a statement.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.